LPL Financial’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14M | Sell |
26,394
-19,436
| -42% | -$8.97M | ﹤0.01% | 1841 |
|
|
2026
Q1 | $22M | Buy |
45,830
+8,993
| +24% | +$4.6M | 0.01% | 1398 |
|
|
2025
Q4 | $20.7M | Buy |
36,837
+10,480
| +40% | +$5.95M | 0.01% | 1386 |
|
|
2025
Q3 | $13.6M | Buy |
26,357
+9,888
| +60% | +$4.32M | ﹤0.01% | 1622 |
|
|
2025
Q2 | $5.17M | Sell |
16,469
-1,905
| -10% | -$572K | ﹤0.01% | 2280 |
|
|
2025
Q1 | $5.47M | Buy |
18,374
+414
| +2% | +$139K | ﹤0.01% | 2077 |
|
|
2024
Q4 | $6.01M | Buy |
17,960
+909
| +5% | +$308K | ﹤0.01% | 1928 |
|
|
2024
Q3 | $5.69M | Buy |
17,051
+714
| +4% | +$271K | ﹤0.01% | 1884 |
|
|
2024
Q2 | $6.73M | Buy |
16,337
+619
| +4% | +$245K | ﹤0.01% | 1641 |
|
|
2024
Q1 | $6.35M | Buy |
15,718
+2,470
| +19% | +$868K | ﹤0.01% | 1616 |
|
|
2023
Q4 | $4.06M | Sell |
13,248
-9,868
| -43% | -$2.66M | ﹤0.01% | 1829 |
|
|
2023
Q3 | $5.6M | Buy |
23,116
+12,380
| +115% | +$3.17M | ﹤0.01% | 1539 |
|
|
2023
Q2 | $2.58M | Buy |
10,736
+438
| +4% | +$91K | ﹤0.01% | 2035 |
|
|
2023
Q1 | $1.94M | Buy |
10,298
+100
| +1% | +$20.7K | ﹤0.01% | 2173 |
|
|
2022
Q4 | $2.14M | Buy |
10,198
+1,230
| +14% | +$246K | ﹤0.01% | 2022 |
|
|
2022
Q3 | $1.41M | Sell |
8,968
-465
| -5% | -$74.2K | ﹤0.01% | 2262 |
|
|
2022
Q2 | $1.43M | Buy |
9,433
+4,274
| +83% | +$619K | ﹤0.01% | 2289 |
|
|
2022
Q1 | $844K | Sell |
5,159
-2,450
| -32% | -$404K | ﹤0.01% | 2753 |
|
|
2021
Q4 | $1.66M | Sell |
7,609
-575
| -7% | -$120K | ﹤0.01% | 2231 |
|
|
2021
Q3 | $1.55M | Buy |
8,184
+305
| +4% | +$55.6K | ﹤0.01% | 2256 |
|
|
2021
Q2 | $1.39M | Sell |
7,879
-1,348
| -15% | -$233K | ﹤0.01% | 2286 |
|
|
2021
Q1 | $1.51M | Sell |
9,227
-1,459
| -14% | -$223K | ﹤0.01% | 2047 |
|
|
2020
Q4 | $1.49M | Sell |
10,686
-314
| -3% | -$39.6K | ﹤0.01% | 1883 |
|
|
2020
Q3 | $1.23M | Sell |
11,000
-408
| -4% | -$47.2K | ﹤0.01% | 1776 |
|
|
2020
Q2 | $1.06M | Buy |
11,408
+883
| +8% | +$75.1K | ﹤0.01% | 1775 |
|
|
2020
Q1 | $772K | Buy |
+10,525
| New | +$914K | ﹤0.01% | 1795 |
|
|
2017
Q3 | – | Sell |
-10,524
| Closed | -$309K | – | 2906 |
|
|
2017
Q2 | $309K | Sell |
10,524
-2,194
| -17% | -$61.5K | ﹤0.01% | 2270 |
|
|
2017
Q1 | $386K | Buy |
12,718
+572
| +5% | +$18.5K | ﹤0.01% | 2018 |
|
|
2016
Q4 | $436K | Sell |
12,146
-1,662
| -12% | -$55.4K | ﹤0.01% | 1849 |
|
|
2016
Q3 | $414K | Buy |
+13,808
| New | +$403K | ﹤0.01% | 1878 |
|
Other funds holding MEDP
WA
LPL Financial's MEDP Position: Q2 2026 in Review
LPL Financial reduced its Medpace (MEDP) stake by 42% in Q2 2026, selling an estimated $8.97M and leaving 26,394 shares worth $14M. The position accounts for ﹤0.01% of the portfolio, ranked #1841.
LPL Financial first reported a position in MEDP in Q3 2016 and has held it in 30 quarters since. The position peaked at $22M in Q1 2026. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- LPL Financial held 26,394 shares of Medpace worth $14M as of Q2 2026.
- LPL Financial sold 19,436 Medpace shares in Q2 2026, an estimated $8.97M.
- Medpace made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #1841 holding.
- LPL Financial first reported a position in Medpace in Q3 2016 and has held it in 30 quarters since.
- LPL Financial's Medpace position peaked at $22M in Q1 2026.
- 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.